Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$KRTL News Alert: The Company Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL's wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL News: Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL and $MMMW news about being pioneers of their technology group.
$KRTL ~ KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.htm
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$RGGI and $MMMW recent technology news. Please check it out.
$KRTL's wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL News Alert: Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL ~ KRTL International is a consultation and distribution company focused on technology and innovations to help greater profitability, social governance, and environmental outcomes to increase and support the 2030 Agenda.
***AI***LOW-FLOAT-UNDERVALUED-PLAY -https://www.otcmarkets.com/stock/SPOM/security
WOW $SPOM $2,000,000 IN CASH-https://www.nasdaq.com/press-release/spo-global-inc.-announces-strong-1st-quarter-financial-operations-and-performance
$RGGI News: ResGreen Awarded New Contract for an Automatic Guided Vehicle (AGV) and Software System
SHELBY TOWNSHIP, Mich., June 08, 2023 (GLOBE NEWSWIRE) -- ResGreen Group (OTC PINK: RGGI) ResGreen Group International, Inc. (the "Company"), a next-gen mobile robot and software solutions company, announced today it signed a contract with a top automotive supplier to manufacture, integrate and install its BigBuddy AGV and BotWay traffic management software. BigBuddy will deliver full pods on a customized load handling frame from an assembly line station to the staging area. It will then return an empty pod to the station.
"ResGreen is on a streak of sales success, adding another large contract in the second quarter," said Parsh Patel, ResGreen's CEO. "Customers are impressed with our cost-effective products that are exceedingly robust and easy to install and maintain, as well as our dedicated customer service."
Currently, workers manually move the carts to and from assembly stations and staging areas. BigBuddy will automate this process, reducing non-valued-added tasks and creating a safer environment. The bidirectional BigBuddy is one of the most robust AGVs in the industry that can move loads up to 5,000 pounds
In the automated system, when a pod is full, an associate pushes ResGreen's wireless button, signaling that a full cart needs to be picked up. Next, BotWay directs BigBuddy to where the full load is located. When BigBuddy reaches the staging area, BotWay updates the staging software to alert a fork truck driver that there is a full pod. The driver then exchanges the full pod on BigBuddy with an empty pod and updates the status on BotWay using a mobile tablet.
About ResGreen Group International, Inc. (RGGI)
ResGreen is a premier provider of automated material handling solutions, including interoperable software, Autonomous Mobile Robots (AMRs), Automatic Guided Vehicles (AGVs) and industrial automation devices. Connectivity and collaboration are the cornerstones of ResGreen's products, which are both WiFi and LoRa compatible for flexible communication. ResGreen's team of experienced engineers use the Internet of Things (IoT), MQTT protocol and Robot Operating System (ROS) to design technologies that interface with a wide variety of automated equipment, electronic components and software systems. For more information, visit http://www.resgreengroup.com. Follow us on LinkedIn and Twitter.
Forward Looking Statement
This news release includes certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include general business, economic, competitive, regulatory, markets and other conditions, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. No information in this news release should be construed as any indication whatsoever of the Company's future stock price, revenues, or results of operations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Contact:
Sarah Carlson
scarlson@resgreengroup.com
$CYCA ACCESSWIRE / June 7, 2023 / Cytta Corp (OTCQB:CYCA), is pleased to announce that Global Medical Response (GMR), a long-time IGAN 1.0 industry customer, has elected to upgrade its incident command infrastructure to our new IGAN 2.0 AIMS (Actionable Intelligence Management System). This strategic decision by GMR will significantly enhance their ability to deliver critical care and emergency response services in future disaster situations worldwide.
GMR, as a prime contractor for FEMA, delivers comprehensive firefighting services, emergency medical response, emergency medical transportation and disaster management nationally through its 38,000 personnel. As the first responders to disasters of all kinds, GMR plays a pivotal role in mitigating risks, ensuring public safety, and preserving property.
"We are delighted to announce GMR's decision to upgrade to IGAN 2.0 after recent demonstrations conducted for the first time with a Drone America drone. The instant connectivity and integration of the IGAN 2.0 with the drone showed the versatility of our new product, " said Gary Campbell, CEO at Cytta Corp. "As GMR's trusted technology partner, we are proud to support GMR in their mission to protect lives and property. The full potential of what we built the IGAN for is realized in this application of the technology," further stated Mr. Campbell.
IGAN 2.0 is an advanced communications platform specifically designed for emergency response organizations. This state-of-the-art solution offers a comprehensive set of mission-critical tools including real-time video sharing, video/voice calls, chat interaction, streaming drone video, location maps, messages, and communications (video/voice/text). With end-to-end encryption and a user-friendly interface, IGAN 2.0 facilitates seamless and secure communication among drone pilots, ground teams, and the OEM Command Center, even in remote and challenging environments. With its robust network infrastructure, IGAN 2.0 ensures uninterrupted connectivity, even in challenging environments, empowering GMR to ensure continuity of operations, real-time situational awareness, and interagency operability.
Cytta Corp's expertise lies in developing robust and reliable communication platforms that address the unique challenges faced by emergency responders. Through extensive research and development, Cytta Corp has created state-of-the-art solutions that revolutionize communication infrastructure to support critical operations. Their commitment to excellence and continuous innovation positions them as a leader in the field, providing tailored solutions that empower GMR and all other first responders to deliver exceptional emergency response services. https://finance.yahoo.com/news/cytta-corp-announces-global-medical-120000215.html
$KRTL May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
https://www.krtlholding.com/about
$KRTL ~ KRTL International Corp. had three team members participate as advisors alongside with Park Kyung-il, a professor of horticulture at Yeungnam University, and two professors in the evaluation of the hemp cultivation division of the Industrial Hemp Special Regulatory Free Zone in South Korea.
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
$KRTL pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
https://www.morningstar.com/news/globe-newswire/8847936/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$KRTL Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
https://www.krtlholding.com/about
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$KRTL Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
https://www.krtlholding.com/about
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
***AI***-STOCK-PLAY-***AI***-NEWS-https://www.nasdaq.com/press-release/spo-global-inc.-adopts-initiative-to-implement-artificial-intelligence-ai-in-its-food
***AI***LOW-FLOAT-UNDERVALUED-PLAY -https://www.otcmarkets.com/stock/SPOM/security
WOW $SPOM $2,000,000 IN CASH-https://www.nasdaq.com/press-release/spo-global-inc.-announces-strong-1st-quarter-financial-operations-and-performance
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
https://www.nasdaq.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered
$KRTL Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$PLPL The valuation was conducted using ByoPlanet's unaudited financial statements for the years ended December 31, 2020 - 2022, and ByoPlanet's internal five-year financial projections based upon an analysis of the financial metrics from 10 leading publicly traded companies in the same sector as ByoPlanet.
https://www.marketwatch.com/press-release/third-party-valuation-firm-provides-estimated-valuation-of-byoplanets-a-subsidiary-of-plandai---plpl-business-and-assets-2023-05-31?mod=mw_quote_news_seemore
BOOM! $DBMM DONE! Only 800 mil OS have the same IHUB bashers on GTII! BOTH Kramer/ALPINE tickers. Learn the history and know why this is special. To much to text!
$DBMM today JUNE 2 2023. SEC dismissed a series of proceeding in front of the SEC Commision 1 of which is us!!!!!!!!!!!! BOOM CASE DISMISSED!!!! See last page I will screenshot. @HAMShortkiller @Dozer8210 @FaiJam3 @settlethetrades @DigitalClarity https://t.co/W5hBMZfzLI pic.twitter.com/IineFGfBCp
— RRR1 (@rrr1sr) June 3, 2023
$MGRX hot sector here: Mangoceuticals Inc. (NASDAQ: MGRX) and the Booming Men's Health Market https://finance.yahoo.com/news/mangoceuticals-inc-nasdaq-mgrx-booming-090000583.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL News: Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$IVDN News: Innovative Designs, Inc. Receives Significant New Orders for Its Unmatched Insultex House Wrap from Two Repeat Customers
PITTSBURGH, PA, June 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -Innovative Designs, Inc. (OTCQB: IVDN) is pleased to report that the company has just received significant new orders for its Insultex House Wrap(R) insulation from two separate customers in the Midwest region of the US. These orders are being processed and shipped at the present time.
One order was from Lindus Construction, Inc. in Wisconsin, which has been installing our Insultex(R) House Wrap on their clients' homes for many years. Lindus Construction understands the great advantages of Insultex(R) House Wrap over other home insulation options and offers a strong endorsement of our product on their own website here: https://lindusconstruction.com/blog/insultex-house-wrap-future-home-weatherization/
The second order was from a repeat customer in Minnesota which is a manufacturer of modular homes. This is another excellent application of Insultex(R) House Wrap for superior energy savings and other high value benefits to enhance the long term value of the homes where it is installed. Better insulation means lower energy bills, better home protection from the elements and also a reduction in carbon output from energy suppliers for a better environment.
Insultex(R) House Wrap delivers an unmatched R-6 rating because of our unique and patented vacuum cell structure design. No other product on the market today offers a vacuum cell structure. It has been proven that a vacuum is the best insulation and Insultex(R) incorporates countless vacuum evacuated cells. Insultex(R) consists of a three-dimensional network of evacuated cells resulting in the creation and enforcement of a thermal energy tortuous path within the Insultex(R) that delivers energy saving results far superior to competitive products.
Innovative Designs Inc. CEO, Joseph Riccelli, commented, "We are very glad to see the latest repeat orders coming in from our good customers who understand and appreciate the unequalled performance of Insultex House Wrap(R). The homes being equipped with our state-of-the-art insulation technology will enjoy far superior energy savings as well as a moisture barrier and other key benefits which will add greatly to their own value. We welcome more home builders and re-modelers to come to us for Insultex House Wrap(R) so that they can start incorporating the game changing advantages of this unique product into their work as well."
About Innovative Designs Inc.
Innovative Designs, Inc. manufactures the Insultex(R) House Wrap and Arctic Armor(R) Line, under the "i.d.i.gear" label featuring INSULTEX(R). Patented INSULTEX(R) is the thinnest, lightest and warmest insulator in the market today. For more information, please visit http://www.idigear.com or http://www.insultexhousewrap.com.
Disclaimer
Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov.
CONTACT:
Joseph Riccelli
412-799-0350
joer@idigear.com
$KRTL The Company Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL news: Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$INTK CEO/CTO in Kuwait @ headquarters of KOC June 20, 2023. AM in conference room training execs & engineers & field technicians on correct application & uses of EPX-H2O on upcoming large projects. Afternoon is field training & applications to equipment.
— Industrial Nanotech Inc (@indnanotech) June 1, 2023
DBMM been double printing for about 2 weeks now
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
https://www.krtlholding.com/about
$KRTL ~ KRTL International is a consultation and distribution company focused on technology and innovations to help greater profitability, social governance, and environmental outcomes to increase and support the 2030 Agenda.
$KRTL ~ KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp.
KRTL on alert! Recent news can be found here https://www.krtlholding.com/news
$KRTL ~ KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group, Inc. (OTC: KRTL), is a research and development company that has a focus in the biotechnology space.
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
Followers
|
287
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
54874
|
Created
|
02/20/15
|
Type
|
Free
|
Moderator mick | |||
Assistants Nilbud ospreyeye jedijazz imgoingfishing1 PhotoChick $Pistol Pete$ |
WELCOME FRIENDS TO "MICK AND FRIENDS STOCK PICKS" BOARD !!!
PLEASE POST :
1. YOUR STOCK PICK
2. WHY YOU ARE RECOMMENDING THE STOCK
3. A BIT OF INFO ON STOCK WOULD BE HELPFUL
FORUM FOR ALL STOCKS:
- NYSE
- NASDAQ
- AMEX
- OTCBB
- PINK SHEETS
- GRAY SHEETS
- FOREIGN EXCHANGES
FORUM NOT FOR ANY SPECIFIC STOCK
PLEASE, YOUR POST MUST NOT CONTAIN ANYTHING ABOUT "BASHING" ON ANY I-HUB STOCK BOARD.
THANK YOU AND ENJOY "MICK AND FRIENDS STOCK PICKS" BOARD.
Mick
PhotoChick
http://investorshub.advfn.com/STOCKGOODIES-PLAYS-OF-THE-WEEK-18582/
Photo Chick
Ospreyeye
Pistol Pete
Nilbud
imgoingfishing1
RECOMMENDED LINKS:
- FEATURE HISTORIANS CREATURES HIGHLIGHTS: http://investorshub.advfn.com/Weekend-Warrior$-27071/
- BUD-X-EXCHANGE HUGE MARIJUANA CANNABIS HEMP FINDS
- STOCKGOODIES PLAYS OF THE WEEK
- http://Pennystocksinsiders.com
- Billionaire Boys Club Member Forum (BBCMF
- INTELLECTUAL STOCK INVESTOR { I S I
- $$$Ospreyeye: Charts, Technical Analysis & Japanese
-Best of iHub
Moderator: JAYLIN Assistants: OTCRIDDLER, OTC_Skywalker, Sonic Boom, norcalpsl, Penny Soldier
LINKS
http://www.thehotpennystocks.com/Stock-Quotes/?stock=VTPI
http://www.quotemedia.com/
http://www.quotemedia.com/finance/quote/?qm_page=73166&qm_symbol=EFFI
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Posts Today
|
0
|
Posts (Total)
|
54874
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |